We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SENATE PANEL MAY PROBE DRUGMAKER OVERCHARGES TO HOSPITALS
SENATE PANEL MAY PROBE DRUGMAKER OVERCHARGES TO HOSPITALS
July 27, 2004
The Senate Finance Committee is demanding an investigation into drug companies responsible for overcharging federal health programs for pharmaceuticals; the committee is also hinting that it may be time to get tougher with delinquents.